To evaluate the effectiveness of psychiatric counseling in reducing the rate of development of psychiatric side effects of antiviral therapy with interferon-α and ribavirin among study participants compared with standard clinical monitoring alone. Interferon-α is used to treat chronic hepatitis C. Interferons may induce adverse events that usually, but not always, reverse within a few days after the end of therapy. © 2010 Lippincott Williams & Wilkins, Inc.
A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin
Neri S.;Bertino G.Conceptualization
;Petralia A.;Calvagno G. S.;Mauceri B.;Boemi P.;Di Pino A.;Ignaccolo L.;Misseri M.;Maiorca D.;Palermo F.
2010-01-01
Abstract
To evaluate the effectiveness of psychiatric counseling in reducing the rate of development of psychiatric side effects of antiviral therapy with interferon-α and ribavirin among study participants compared with standard clinical monitoring alone. Interferon-α is used to treat chronic hepatitis C. Interferons may induce adverse events that usually, but not always, reverse within a few days after the end of therapy. © 2010 Lippincott Williams & Wilkins, Inc.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
A Multidisciplinary Therapeutic Approach 2010.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
316.72 kB
Formato
Adobe PDF
|
316.72 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
